• Policy
• Dong-A ST’s Forxiga prodrug Dapapro 5mg listed for reimb
• by Lee, Tak-Sun Dec 26, 2022 06:07am

• Policy
• Zavicefta has been approved for domestic use
• by Lee, Hye-Kyung Dec 26, 2022 06:06am

• Policy
• Exclude Australia from the drug price reference country?
• by Lee, Tak-Sun Dec 26, 2022 06:06am

• Policy
• Revlimid's benefit for multiple myeloma maintenance therapy
• by Lee, Tak-Sun Dec 23, 2022 06:05am

• Policy
• Lucentis biosimilar price set 63% lower than original
• by Lee, Tak-Sun Dec 23, 2022 06:05am

• Policy
• New reimbursement standards set for Kymriah·Zolgensma
• by Kim, Jung-Ju Dec 22, 2022 05:52am

• Policy
• Lucentis biosimilar enters KRW 35B market in Korea
• by Lee, Tak-Sun Dec 21, 2022 06:05am

• Policy
• Shingrix will be released as a national lot on the 16th
• by Lee, Tak-Sun Dec 21, 2022 06:05am

• Policy
• Pfizer & Novartis generic drugs disappear from the market
• by Lee, Tak-Sun Dec 20, 2022 06:06am

• Policy
• President Yoon said, block medical shopping
• by Kang, Shin-Kook Dec 20, 2022 06:05am